用药物涂层气球在左侧主要分叉病变中的复合结果:系统性审查
Yang Cheng1, Yong Chen1, Bao-Tao Huang1
1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Journal of geriatric cardiology : JGC
|December 30, 2024
概括
药物涂层气球 (DCBs) 在治疗左主冠状动脉分支病变方面显示出有希望的结果,比传统方法提供了可比或更好的结果. 建议进行进一步的研究,包括随机对照试验.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 左主冠状动脉分支病变是冠状动脉疾病的一个重大挑战,占病例的50%.
- 药物涂层气球 (DCB) 提供了潜在的优势,如直接药物输送和没有永久的支架.
研究的目的:
- 系统地审查药物涂层气球 (DCBs) 在治疗左主冠状动脉分支病变中的有效性和安全性.
- 为了将DCB结果与药物释放支架和传统气球进行比较.
主要方法:
- 按照PRISMA指南进行了系统审查.
- 包括18个回顾性和2个前性研究,涉及使用DCBs治疗的左主分支病变.
- 研究被分为"只有DCB"和"DCB + 支架"组.
主要成果:
- 中期随访表明,与药物释放支架或常规气球相比,DCBs的血管和临床结果不低于或优于DCBs.
- 在 de novo 和 in-stent 静止病变中,DCBs 已显示出有效性.
- 观察到的侧枝晚期光量扩大表明DCB对侧枝的潜在保护作用.
结论:
- DCB技术在治疗左主分叉病变方面具有良好的安全性和有效性.
- 需要进一步的研究,特别是随机对照试验,以确定DCB使用的最终标准.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...